In the Original Investigation titled “Artificial Intelligence–Detected Tumor-Infiltrating Lymphocytes and Outcomes in Anti–PD-1–Based Treated Melanoma,” published online October 16, 2025, and in the December 2025 issue, there were errors in Tables 2 and 3. In Table 2, in the univariable column, the measures for progression-free survival and overall survival were corrected to hazard ratios; in the multivariable column, the measures for overall response rate were corrected to odds ratios.
In Table 3, the measures for progression-free survival were corrected to hazard ratios. This article was corrected online.
JAMA Oncology published a clinical update in Oncology on 02 Apr 2026.
The item focuses on Error in Tables 2 and 3.
Review the original article for the full source wording and details.